These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 6090917)
1. In silico screening of GMQ-like compounds reveals guanabenz and sephin1 as new allosteric modulators of acid-sensing ion channel 3. Callejo G; Pattison LA; Greenhalgh JC; Chakrabarti S; Andreopoulou E; Hockley JRF; Smith ESJ; Rahman T Biochem Pharmacol; 2020 Apr; 174():113834. PubMed ID: 32027884 [TBL] [Abstract][Full Text] [Related]
2. Use of guanabenz in methadone withdrawal. Levadi DI Am J Psychiatry; 1985 Sep; 142(9):1128-9. PubMed ID: 4025641 [No Abstract] [Full Text] [Related]
3. Clinical experience with naltrexone in suburban opioid addicts. Tennant FS; Rawson RA; Cohen AJ; Mann A J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935 [TBL] [Abstract][Full Text] [Related]
4. [Use of presynaptic alpha-mimetics for withdrawal in heroin addicts]. Gorceix A; Dugarin J; Pommier F Ann Med Interne (Paris); 1985; 136(5):389-92. PubMed ID: 2865924 [TBL] [Abstract][Full Text] [Related]
5. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600 [TBL] [Abstract][Full Text] [Related]
6. Guanabenz acetate: a new, long-acting alpha-two adrenergic agonist for opioid withdrawal. Tennant FS; Rawson RA NIDA Res Monogr; 1984 Mar; 49():338-43. PubMed ID: 6090917 [TBL] [Abstract][Full Text] [Related]
7. Current pharmacotherapies for opioid dependence. Kosten TR Psychopharmacol Bull; 1990; 26(1):69-74. PubMed ID: 2196628 [TBL] [Abstract][Full Text] [Related]
8. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine. Gold MS Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic interventions for the treatment of opioid dependence and withdrawal. Guthrie SK DICP; 1990; 24(7-8):721-34. PubMed ID: 2197814 [TBL] [Abstract][Full Text] [Related]
10. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Honey BL; Benefield RJ; Miller JL; Johnson PN Ann Pharmacother; 2009 Sep; 43(9):1506-11. PubMed ID: 19690220 [TBL] [Abstract][Full Text] [Related]
11. [α2-Agonists during withdrawal]. Tonner PH; Paris A Pharm Unserer Zeit; 2011 Nov; 40(6):481-2. PubMed ID: 22028132 [No Abstract] [Full Text] [Related]